<DOC>
	<DOCNO>NCT01479205</DOCNO>
	<brief_summary>One aim study find bronchial allergen provocation ( BAP ) appropriate method appraise efficacy specific immunotherapy ( SIT ) . The investigator one group child receive SIT one group patient deny SIT although indication . Retrospectively investigator analyse data first BAP blood parameter specific IgE-mite , total IgE SIT ( November 2008 till February 2010 ) . Prospectively The investigator analyse lung parameter allergic labor parameter get course second BAP . The investigator mean parameter PD20FEV1-mite . Another aim The investigator study find specific immunological difference child improve SIT show improvement . Thus , The investigator compare level total IgE , cumulative IgE-mite specific IgE-mite SIT level specific IgG-mite specific IgG4-mite SIT .</brief_summary>
	<brief_title>Induction Allergen Specific Bronchial Immunotolerance After Specific Immunotherapy</brief_title>
	<detailed_description>One aim study find bronchial allergen provocation ( BAP ) appropriate method appraise efficacy specific immunotherapy ( SIT ) . We one group child receive SIT one group patient deny SIT although indication . Retrospectively analysed data first BAP ( PD20FEV1 , VC , FEV1 , FEV1/VC ( % ) , eNO ) allergic blood parameter like specific IgE-mite , total IgE , cumulative IgE SIT ( November 2008 till February 2010 ) . Prospectively analysed lung parameter allergic labor parameter get course second BAP . Our mean parameter PD20FEV1-mite . Another aim study find specific immunological difference child improve SIT show improvement . Thus , compare level total IgE , cumulative IgE-mite specific IgE-mite SIT level specific IgG-mite specific IgG4-mite SIT . Additionally patient answer questionnaire accord ISAAC clinical symptom , quality life medication score .</detailed_description>
	<criteria>inform consent 5 18 year age diagnosis moderate Asthma bronchiale ( III ) last 12 month rhino conjunctivitis exacerbation &gt; 4 week Visit age &lt; 5 year &gt; 18 year , FEV1 &lt; 75 % cooperation undergo BAP , exacerbation within last 28 day Visit serious illness take part clinical trial &lt; 30 day</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>specific immunotherapy</keyword>
	<keyword>bronchial allergen provocation</keyword>
	<keyword>specific IgE</keyword>
	<keyword>specific IgG</keyword>
	<keyword>specific IgG4</keyword>
	<keyword>SIT</keyword>
</DOC>